The Centers for Medicare and Medicaid Services (CMS) is updating its rules to encourage states, payers, and Medicare programs to enter value-based payment arrangements (VPA) with drug manufacturers to help reduce drug costs. What does this mean for Medicare providers and beneficiaries?